Century Therapeutics
Arpit Shah, Ph.D., currently serves as a Senior Scientist in Analytical Development at Century Therapeutics, Inc., and previously held the position of Senior Bio-analytical Scientist at Spark Therapeutics, Inc. from September 2019 to January 2022. Prior to that, Arpit worked as a Research Scientist at QPS Holdings, LLC, where responsibilities included leading a lab team for method development and validation in a GLP environment. Arpit has extensive teaching experience, including roles as an Adjunct Professor at Temple University and a RISE Tutor at the Community College of Philadelphia. Educationally, Arpit obtained a Ph.D. and a Master's Degree in Biomedical Engineering from Drexel University, where various research initiatives were focused on hepatocellular carcinoma and intracranial pressure sensors.
Century Therapeutics
1 followers
Century Therapeutics is harnessing the power of stem cells to develop curative cell therapy products for cancer.